How intravenous drips of vitamins are becoming popular and why doctors flag them as unnecessary

A person associated with a wellness centre in Gurgaon says on condition of anonymity that the vitamin IV “therapy” is gaining traction and the footfall the centre is getting is increasing every month. “The number of people opting for IV vitamins has gone up by 30-40% over last year,” he says, adding, “We offer packages depending on what one wants. A screening is done by our in-house doctor and then a cocktail is decided.” Instead of popping multivitamin tablets, why do people opt for intravenous drips? “When vitamins are taken orally, the absorption rate is 20-50%. However, it is 90-100% when it is given intravenously,” the person says. It is sought by people in the metros, he adds.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MbpW7Gf
via IFTTT

Read More

Drug sales get a monsoon twist in August

Liver herbal supplement Liv 52 emerged as one of India's top-selling herbal tonics in August, driven by increased cases of liver-related illnesses during the monsoon season. The Indian pharmaceutical market saw a 6.3% growth year-over-year, with gastrointestinal and anti-diabetic medications performing strongly in both sales value and volume.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EyuMvXq
via IFTTT

Read More

Ayushman Bharat enrollment for senior citizens to start in a week

Enrollment for senior citizens aged 70 and above under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) will begin soon. Initially launching as a pilot program, eligible seniors can apply through the Ayushman mobile app or PMJAY portal. The scheme offers free health insurance coverage of up to Rs 5 lakh annually on a family basis.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yDRJhuM
via IFTTT

Read More

Healthcare, manufacturing sector to benefit most from Fed rate cuts: Motilal Oswal

As the U.S. Federal Reserve's anticipated rate cut approaches, a report by Motilal Oswal suggests that the healthcare and manufacturing sectors are expected to benefit the most. Healthcare is projected to be the fastest-growing sector, while manufacturing may see technological advancements. Challenges remain for BFS, retail, and hi-tech industries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Rd8yeFZ
via IFTTT

Read More

Alkem joins $3 bn race for JB Chem as Torrent pauses talks

Alkem Laboratories, India's fifth-largest branded pharmaceutical company, is vying for JB Chemicals and Pharmaceuticals as KKR looks to sell. Torrent Pharmaceuticals has exited negotiations over valuation differences. If successful, this will be Alkem's largest acquisition, enhancing its presence in the chronic segment and potentially moving it to fourth place in the domestic formulations market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WFzC6X1
via IFTTT

Read More

Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector

Biocon Chairperson Kiran Mazumdar-Shaw urges increased investment in research and development to drive innovation and intellectual property culture. Speaking at Global Bio-India 2024, she highlights India's potential as a global bio-innovation hub, emphasizing its scientific talent and technological capabilities. She also underscores the importance of biotechnology in healthcare and agriculture.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sRV9xg0
via IFTTT

Read More

DNA Wellness to invest Rs 200 cr to set up over 100 cervical cancer screening labs

Ahmedabad-based DNA Wellness will invest Rs 200 crore to establish over 100 cervical cancer screening labs across India by 2027. The company has exclusive rights to conduct the DNA Ploidy Test, developed by the British Columbia Cancer Research Agency. The first CERViSure lab has been launched in Ahmedabad, with plans for more labs in Gujarat by October 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mSZtNxk
via IFTTT

Read More